As of November 6, 2026, 3 holders' latest Schedule 13D or 13G filings report owning 5% or more of Novavax, Inc. The largest reported stake is State Street Corporation's, at 7.1%. 12 filings are on record since October 14, 2025 (Schedule 13G, August 7, 2026).
Sell to companies like Novavax, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Holder: Himanshu H. Shah · Percent: 6.46% · Shares: 10,656,964 · SCHEDULE 13G
- · Holder: Shah Capital Management · Percent: 6.46% · SCHEDULE 13D/A
- · Reporting person: State Street Corporation · Sole voting: 0 · Shared voting: 11,281,036 · Sole dispositive: 0 · Shared dispositive: 11,740,566 · SCHEDULE 13G, 2026-08-07
- · Holder: Shah Capital Management · Percent: 9.03% · SCHEDULE 13D/A
- · Holder: Vanguard Capital Management · Percent: 5.09% · SCHEDULE 13G
Novavax, Inc. has 12 Schedule 13D or 13G filings on record since 2025-10-14. 3 holders' latest filing reports 5% or more of common stock, par value $0.01 per share. Each figure below is the holder's own, as filed, with the filing linked.
Stated intent
Intent stated in Item 4 Shah Capital Management
Item 4 is hereby amended to add the following: On April 8, 2026, the Reporting Persons sent a letter (the "Shah Capital Open Letter") to the board of directors of the Issuer (the "Board") declaring a notice of intention to vote against Board Nominees and Executive Compensation.From Item 4 of the SCHEDULE 13D/A filed 2026-04-08
Intent stated in Item 4 Shah Capital Management
Item 4 is hereby amended to add the following: On October 13, 2025, the Reporting Persons sent a letter (the "Shah Capital NVAX BOD Letter") to the board of directors of the Issuer (the "Board") urging the Board to undertake a formal strategic review, including an evaluation of a potential sale of the Issuer.From Item 4 of the SCHEDULE 13D/A filed 2025-10-14
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| State Street Corporation | 7.1% | 11,740,566 | SCHEDULE 13G, 2026-08-07 | 2026-06-30 |
| 6.46% | 10,656,964 | SCHEDULE 13G, 2026-10-16 | 2026-10-16 | |
| Vanguard Capital Management | 5.09% | 8,305,681 | SCHEDULE 13G, 2026-04-30 | 2026-03-31 |
| Bank Of America Corp | 4.1% | 6,655,398 | SCHEDULE 13G/A, 2026-04-27 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
Holding shares or following this stake? See who's behind Novavax, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Novavax, Inc. and the records around it.
Novavax, Inc. elsewhere on the record
Companies that share a holder
- Shah Capital Management also filed stake reports on 3 other companies: VEON Ltd. (Oct 2026), Cheer Holding, Inc. (Oct 2025)
- BANK OF AMERICA CORP /DE/ also filed stake reports on 74 other companies: BlackRock 2037 Municipal Target Term Trust (Nov 2026), TRIMAS CORP (Nov 2026), PIMCO CALIFORNIA MUNICIPAL INCOME FUND (Nov 2026)
- STATE STREET CORPORATION also filed stake reports on 343 other companies: TRADE DESK INC/THE (Oct 2026), CENTRUS ENERGY CORP (Sep 2026), ACADIA PHARMACEUTICALS INC (Aug 2026)
Watch Novavax, Inc.
Get an email when Novavax, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Novavax, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Novavax, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Novavax, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| State Street Corporation | 0 | 11,281,036 | 0 | 11,740,566 | SCHEDULE 13G, 2026-08-07 |
| Shah Capital Management | 0 | 10,543,476 | 0 | 10,543,476 | SCHEDULE 13G, 2026-10-16 |
| Shah Capital Fund LLC | 0 | 6,230,000 | 0 | 6,230,000 | SCHEDULE 13G, 2026-10-16 |
| Himanshu H. Shah | 113,488 | 10,543,476 | 113,488 | 10,543,476 | SCHEDULE 13G, 2026-10-16 |
The latest filing identifies Novavax, Inc. by CUSIP 670002401 and gives its principal executive office as 21 FIRSTFIELD ROAD, GAITHERSBURG, MD 20878 (SCHEDULE 13G, 2026-10-16).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-10-14 | Shah Capital Management intent stated | 7.3% | SCHEDULE 13D/A |
| 2025-11-12 | Shah Capital Management | 8.3% | SCHEDULE 13D/A |
| 2026-02-09 | State Street Corporation | 5.9% | SCHEDULE 13G |
| 2026-02-11 | Bank Of America Corp | 5.1% | SCHEDULE 13G |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-08 | Shah Capital Management intent stated | 9.11% | SCHEDULE 13D/A |
| 2026-04-27 | Bank Of America Corp | 4.1% | SCHEDULE 13G/A |
| 2026-04-30 | Vanguard Capital Management | 5.09% | SCHEDULE 13G |
| 2026-05-15 | Shah Capital Management | 9.03% | SCHEDULE 13D/A |
| 2026-08-07 | State Street Corporation | 7.1% | SCHEDULE 13G |
| 2026-10-16 | Shah Capital Management | 6.46% | SCHEDULE 13D/A |
| 2026-10-16 | Himanshu H. Shah | 6.46% | SCHEDULE 13G |
Questions about who owns Novavax, Inc.
Who owns Novavax, Inc.?
On this page, 3 holders' latest ownership filings report 5% or more of Novavax, Inc.: State Street Corporation (7.1%, Schedule 13G, filed 2026-08-07), Himanshu H. Shah (6.46%, Schedule 13G, filed 2026-10-16) and Vanguard Capital Management (5.09%, Schedule 13G, filed 2026-04-30).
Who are the largest shareholders of Novavax, Inc.?
By the share each holder's latest filing reports, the largest holders of Novavax, Inc. on this page are State Street Corporation (7.1%), Himanshu H. Shah (6.46%) and Vanguard Capital Management (5.09%).
When did State Street Corporation buy into Novavax, Inc.?
The filings give report dates, not purchase dates. The earliest filing from State Street Corporation on this page is the Schedule 13G, filed 2026-02-09, reporting 5.9%; its latest, Schedule 13G filed 2026-08-07, reports 7.1%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Novavax, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.